<DOC>
	<DOCNO>NCT01857206</DOCNO>
	<brief_summary>Evaluate safety tolerability TIVa TIVb vaccine healthy child adolescents 4 17 year age .</brief_summary>
	<brief_title>Safety Two Trivalent Influenza Vaccines Evaluated Children Adolescents 4 17 Years Age</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject 417 year age Subjects healthy , Subjects pregnant breast feeding , Subjects history severe allergic reaction allergic vaccine component .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>child adolescent</keyword>
	<keyword>trivalent vaccine</keyword>
	<keyword>cell culture</keyword>
	<keyword>embryonated chicken egg</keyword>
</DOC>